The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22125
StudyName: Eligibility Multiple Myeloma NCT00441168
Date of export from the portal: 02.07.2020
Date of Upload / last change: 20.05.2017
License: Creative Commons BY 4.0

----

Description: 
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00441168
